Matches in Wikidata for { <http://www.wikidata.org/entity/Q92008497> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- Q92008497 description "2020 nî lūn-bûn" @default.
- Q92008497 description "2020年の論文" @default.
- Q92008497 description "2020年学术文章" @default.
- Q92008497 description "2020年学术文章" @default.
- Q92008497 description "2020年学术文章" @default.
- Q92008497 description "2020年学术文章" @default.
- Q92008497 description "2020年学术文章" @default.
- Q92008497 description "2020年学术文章" @default.
- Q92008497 description "2020年學術文章" @default.
- Q92008497 description "2020年學術文章" @default.
- Q92008497 description "2020年學術文章" @default.
- Q92008497 description "2020年學術文章" @default.
- Q92008497 description "2020年學術文章" @default.
- Q92008497 description "2020년 논문" @default.
- Q92008497 description "article científic" @default.
- Q92008497 description "article scientific" @default.
- Q92008497 description "article scientifique" @default.
- Q92008497 description "articol științific" @default.
- Q92008497 description "articolo scientifico" @default.
- Q92008497 description "artigo científico" @default.
- Q92008497 description "artigo científico" @default.
- Q92008497 description "artigo científico" @default.
- Q92008497 description "artikel ilmiah" @default.
- Q92008497 description "artikull shkencor" @default.
- Q92008497 description "artikulong pang-agham" @default.
- Q92008497 description "artykuł naukowy" @default.
- Q92008497 description "artículo científico publicado en 2020" @default.
- Q92008497 description "artículu científicu" @default.
- Q92008497 description "bilimsel makale" @default.
- Q92008497 description "bài báo khoa học" @default.
- Q92008497 description "naučni članak" @default.
- Q92008497 description "scienca artikolo" @default.
- Q92008497 description "scientific article published on 17 April 2020" @default.
- Q92008497 description "scientific article published on 17 April 2020" @default.
- Q92008497 description "scientific article published on 17 April 2020" @default.
- Q92008497 description "teaduslik artikkel" @default.
- Q92008497 description "tieteellinen artikkeli" @default.
- Q92008497 description "tudományos cikk" @default.
- Q92008497 description "vedecký článok" @default.
- Q92008497 description "vetenskaplig artikel" @default.
- Q92008497 description "videnskabelig artikel udgivet 17. april 2020" @default.
- Q92008497 description "vitenskapelig artikkel" @default.
- Q92008497 description "vitskapeleg artikkel" @default.
- Q92008497 description "vědecký článek" @default.
- Q92008497 description "wetenschappelijk artikel" @default.
- Q92008497 description "wissenschaftlicher Artikel" @default.
- Q92008497 description "επιστημονικό άρθρο" @default.
- Q92008497 description "мақолаи илмӣ" @default.
- Q92008497 description "наукова стаття, опублікована у квітні 2020" @default.
- Q92008497 description "научна статия" @default.
- Q92008497 description "научная статья" @default.
- Q92008497 description "научни чланак" @default.
- Q92008497 description "научни чланак" @default.
- Q92008497 description "מאמר מדעי" @default.
- Q92008497 description "مقالة علمية نشرت في 17 أبريل 2020" @default.
- Q92008497 description "১৭ এপ্রিল ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92008497 description "บทความทางวิทยาศาสตร์" @default.
- Q92008497 description "სამეცნიერო სტატია" @default.
- Q92008497 name "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 name "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 type Item @default.
- Q92008497 label "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 label "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 prefLabel "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 prefLabel "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 P1433 Q92008497-C81C5F3D-3818-4BF1-AB71-722D472E65F3 @default.
- Q92008497 P1476 Q92008497-C8882410-EC47-4386-85E6-6CDA3B4C477D @default.
- Q92008497 P2093 Q92008497-38504CCB-123B-4DEB-A6FD-8B1100410803 @default.
- Q92008497 P304 Q92008497-330CCD9F-8DED-4271-BA35-0D8758D049E5 @default.
- Q92008497 P31 Q92008497-91c19fde-853d-4979-a84a-31de5352e2b5 @default.
- Q92008497 P31 Q92008497-AE8BD593-6CC2-49CE-B3A0-A691214064A6 @default.
- Q92008497 P356 Q92008497-C4C8B383-32C3-4ECB-85DE-65E2359F228B @default.
- Q92008497 P577 Q92008497-C4B3CA16-A1CD-4C6E-9130-B9355AD4F82F @default.
- Q92008497 P6179 Q92008497-478FEE8A-6FCA-4E4A-87DF-48C35EC4F7AD @default.
- Q92008497 P698 Q92008497-1C277084-8DDC-4ADA-AB22-21D1500CF45C @default.
- Q92008497 P8150 Q92008497-8236FA9E-E484-4A0E-909E-DF61D8BACA3B @default.
- Q92008497 P921 Q92008497-29E1EE95-28D9-4689-97F3-BDD756E2A416 @default.
- Q92008497 P921 Q92008497-901733D8-0E5F-476C-98DF-A59467976CFA @default.
- Q92008497 P921 Q92008497-A8FAD696-80B3-4C3B-84A2-08E7B3CC10FA @default.
- Q92008497 P921 Q92008497-D4E5985B-7123-4D1C-8A7C-D077F04C16B0 @default.
- Q92008497 P932 Q92008497-13B4AA32-D181-4E57-98E3-22D744AC7866 @default.
- Q92008497 P356 2047487320920754 @default.
- Q92008497 P698 32301349 @default.
- Q92008497 P1433 Q2493290 @default.
- Q92008497 P1476 "Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia" @default.
- Q92008497 P2093 "Bernhard Rauch" @default.
- Q92008497 P304 "2047487320920754" @default.
- Q92008497 P31 Q13442814 @default.
- Q92008497 P31 Q871232 @default.
- Q92008497 P356 "10.1177/2047487320920754" @default.
- Q92008497 P577 "2020-04-17T00:00:00Z" @default.
- Q92008497 P6179 "1126752788" @default.
- Q92008497 P698 "32301349" @default.
- Q92008497 P8150 "covidwho-72267" @default.
- Q92008497 P921 Q18216 @default.
- Q92008497 P921 Q389735 @default.
- Q92008497 P921 Q82069695 @default.
- Q92008497 P921 Q84263196 @default.
- Q92008497 P932 "7717238" @default.